Current opinions and recommendations of paediatric healthcare professionals - The importance of tablets: Emerging orally disintegrating versus traditional tablets.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
      Drug Prescriptions* ; Health Personnel*; Pediatrics/*methods ; Tablets/*administration & dosage; Administration, Oral ; Airway Obstruction/prevention & control ; Female ; Humans ; Male ; Practice Guidelines as Topic
    • Abstract:
      The appropriate prescribing of paediatric dosage forms is paramount in providing the desired therapeutic effect alongside successful medication adherence with the paediatric population. Often it is the opinion of the healthcare practitioner that dictates which type of dosage form would be most appropriate for the paediatric patient, with liquids being both the most commonly available and most commonly used. Orally disintegrating tablets (ODTs) are an emerging dosage form which provide many benefits over traditional dosage forms for paediatric patients, such as rapid disintegration within the oral cavity, and the reduction in the risk of choking. However the opinion and professional use of healthcare practitioners regarding ODT's is not known. This study was designed to assess the opinions of several types of healthcare professionals (n = 41) regarding ODTs, using a survey across two hospital sites. Results reaffirmed the popularity of liquids for prescribing in paediatrics, with 58.0% of participants preferring this dosage form. ODTs emerged as the second most popular dosage form (30.0%), with healthcare practitioners indicating an increasing popularity amongst patients in the hospital setting, belief with 63.0% of practitioners agreeing that many liquid formulations could be substituted with a suitable ODT. The desired properties of an ideal ODT were also identified by healthcare practitioners preferring a small, fast disintegrating tablet (90.2% and 95.1% respectively), with the taste, disintegration time and flavour being the three most important attributes identified (29.5%, 28.7% and 21.7% respectively). This study provided a pragmatic approach in assessing healthcare professional's opinions on ODTs, highlighting the ideas and thoughts of practitioners who are on the frontline of paediatric prescribing and treatment and gave an indication to their preference for ODT properties.
    • References:
      Ther Innov Regul Sci. 2013 Sep;47(5):533-541. (PMID: 30235574)
      BMC Med Res Methodol. 2013 Sep 18;13:117. (PMID: 24047204)
      Pediatr Emerg Care. 2007 Jun;23(6):384-6. (PMID: 17572522)
      PLoS One. 2013;8(3):e58303. (PMID: 23484012)
      Ann Trop Paediatr. 2011;31(3):235-45. (PMID: 21781419)
      Int J Pharm Pract. 2012 Jun;20(3):191-8. (PMID: 22554162)
      Qual Res Psychol. 2015 Apr 3;12(2):202-222. (PMID: 27499705)
      Int J Pharm. 2014 Aug 5;469(2):257-9. (PMID: 24797763)
      Paediatr Drugs. 2016 Feb;18(1):65-73. (PMID: 26801779)
      Arch Dis Child. 2004 Oct;89(10):943-9. (PMID: 15383439)
      Eur J Hosp Pharm. 2017 Nov;24(6):332-337. (PMID: 31156967)
      J Adv Pharm Technol Res. 2011 Oct;2(4):223-35. (PMID: 22247889)
      Braz J Infect Dis. 2016 Sep-Oct;20(5):429-36. (PMID: 27471126)
      Proc Nutr Soc. 2004 Nov;63(4):655-60. (PMID: 15831139)
      Pediatr Infect Dis J. 2000 Dec;19(12):1148-53. (PMID: 11144374)
      Chem Senses. 2008 Jun;33(5):415-23. (PMID: 18310060)
      Trop Med Int Health. 2001 Jul;6(7):496-504. (PMID: 11469941)
      Arch Otolaryngol Head Neck Surg. 2005 Nov;131(11):970-5. (PMID: 16301368)
      Headache. 2003 Jan;43(1):19-26. (PMID: 12864754)
      Pediatrics. 2015 May;135(5):883-9. (PMID: 25896843)
      Eur J Clin Pharmacol. 2011 May;67(5):449-61. (PMID: 21243345)
      AIDS Care. 2009 Aug;21(8):1025-31. (PMID: 20024759)
      Br J Clin Pharmacol. 2014 Nov;78(5):1080-9. (PMID: 24965935)
      J Adv Nurs. 2005 Apr;50(2):204-11. (PMID: 15788085)
      J Pharmacol Pharmacother. 2011 Apr;2(2):119-20. (PMID: 21772776)
      Yakugaku Zasshi. 2000 Jul;120(7):652-6. (PMID: 10920719)
      J Clin Psychopharmacol. 2006 Feb;26(1):75-8. (PMID: 16415711)
    • Accession Number:
      0 (Tablets)
    • Publication Date:
      Date Created: 20180301 Date Completed: 20180522 Latest Revision: 20240313
    • Publication Date:
      20240313
    • Accession Number:
      PMC5830997
    • Accession Number:
      10.1371/journal.pone.0193292
    • Accession Number:
      29489871